BRAINCO BIOPHARMA

BRAINco Biopharma S.L., a biopharmaceutical company, develops personalized treatments for the illnesses of human central nervous system.

#People #More

BRAINCO BIOPHARMA

Industry:
Biotechnology Health Care Medical Pharmaceutical

Status:
Active



Current Advisors List

raimon-roura_image

Raimon Roura Member of the Board of Directors @ Brainco Biopharma
Board_member

More informations about "Brainco Biopharma"

BRAINco Biopharma S.L. - LinkedIn

Non-profit Organization Management ... BRAINco Biopharma develops innovative diagnostics and therapeutics for diseases of the nervous system through the integration of scientific excellence and ...See details»

Brainco Biopharma - Drug pipelines, Patents, Clinical trials - Synapse

Last update 30 Sep 2024. Brainco Biopharma. Private Company |See details»

Brainco Biopharma - Contacts, Employees, Board Members

Organization. Brainco Biopharma . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. Highlights. Number of Board Member and Advisor Profiles 1. About. โ€ฆSee details»

BRAINco Biopharma SL: Drug pipelines, Patents, Clinical trials

Jun 21, 2023 Explore BRAINco Biopharma SL with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»

BRAINco Biopharma SL - Company Profile and News

BRAINco Biopharma, S.L. develops personal medicine for diseases of the nervous systems. The Company offers epilepsy, neurology, psychiatry, and multiple sclerosis. BRAINco Biopharma โ€ฆSee details»

BRAINco Biopharma SL Company Profile, Financial and ... - digitGaps

BRAINco Biopharma S.L., a biopharmaceutical company, develops personalized treatments for the illnesses of human central nervous system. It develops personal medicine tools for โ€ฆSee details»

BRAINco Biopharma company presentation | PPT

Jun 14, 2012 4. BRAINco Biopharma History 2008 โ€“ Schizophrenia and Major Depression Projects Progenika´s internal research identified, through proteomic and genomic studies, alterations in the expression levels of several genes and โ€ฆSee details»

BRAINco - VentureRadar

BRAINco Biopharma is pioneering in developing Personalized Medicine for Nervous System diseases: Neurology and Psychiatry. BRAINco Mission is the development of new โ€ฆSee details»

Brainco Biopharma - Crunchbase

BRAINco Biopharma S.L., a biopharmaceutical company, develops personalized treatments for the illnesses of human central nervous system.See details»

BRAINco Biopharma S.L. - Overview, Competitors & Emplyee โ€ฆ

BRAINco Biopharma S.L. BRAINco Biopharma develops innovative diagnostics and therapeutics for diseases of the nervous system through the integration of scientific excellence and โ€ฆSee details»

BRAINco Biopharma | Scientist.com

BRAINco Biopharma focuses on research in neurological diseases and psychiatric disorders and develops stable cell lines, optimized cell based assays for High Throughput Screening, lead โ€ฆSee details»

BRAINco Biopharma - Overview, News & Competitors - ZoomInfo

BRAINco Biopharma - Business Information. Healthcare Services · Spain · 27 Employees. BRAINco Biopharma Sl is a company that operates in the Pharmaceuticals industry. It โ€ฆSee details»

BRAINco Biopharma SL:Funding,Funding Rounds,Funding Analysis ...

Discovery Company profile page for BRAINco Biopharma SL including technical research,competitor monitor,market trends,company profile& stock symbolSee details»

BRAINco Biopharma Locations - Contract Research Map

BRAINco Biopharma. Edificio 801. Parque Tecnológico de Vizcaya Derio Bilbao, ... It saves time and money and provides access to innovation while maintaining compliance with an โ€ฆSee details»

Multiple sclerosis(BRAINco Biopharma) - Drug Targets, Indications ...

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»

Patents Assigned to Brainco Biopharma S.L ... - Justia Patents Search

Abstract: A non-human transgenic animal having a polynucleotide encoding an STXBP1 polypeptide, which polynucleotide is operably linked to a promoter, wherein said transgenic โ€ฆSee details»

Bridging Minds and Machines: The Rise of BrainCo and Its โ€ฆ

Nov 1, 2024 BrainCoโ€™s commitment to public welfare aligns with this vision. The company has invested heavily in research and development, with approximately $300 million in financing. โ€ฆSee details»

Neuralink's Progress and the Expansion of Brain-Computer โ€ฆ

May 26, 2023 Meanwhile, BrainCo and MindMaze harness non-invasive BCI to accentuate focus and aid neurorehabilitation, respectively. Given the constant progress in these technologies, โ€ฆSee details»